Emergent Biosolutions Inc

NYSE:EBS   3:46:58 PM EDT
29.68
-0.82 (-2.69%)
Other Pre-Announcement

Emergent Biosolutions Reports Qtrly Total Revenues $242.7 Mln Vs $397.5 Mln

Published: 08/01/2022 21:36 GMT
Emergent Biosolutions Inc (EBS) - Emergent Biosolutions Reports Financial Results for Second Quarter 2022.
Qtrly Total Revenues$242.7 Million Versus $397.5 Million.
Qtrly Loss per Share $1.13.
Sees Total Revenues$1,150 Million -$1,250 Million in 2022.
Qtrly Adjusted Net Income Loss per Diluted Share $0.86.
Q2 Earnings per Share View $0.38, Revenue View $270.9 Million -- Refinitiv Ibes Data (analyst estimates).